search
Back to results

Renal Denervation Using Externally Focused Therapeutic Ultrasound

Primary Purpose

Hypertension

Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Surround Sound Externally Focused Therapeutic Ultrasound
Sponsored by
Kona Medical Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypertension focused on measuring hypertension

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • At least 18 years of age
  • Average systolic blood pressure at least 160 mmHg
  • Refractory, stable hypertension despite being treated with at least three hypertensive drugs
  • Two functioning kidneys, defined as eGFR >= 45 ml/min
  • At least one renal artery on each side which is greater than 4 mm.

Exclusion Criteria:

  • History of nephrectomy or hydronephrosis
  • Renal stenosis > 50%
  • Renal stent
  • Ambulatory blood pressure monitoring 24 hour average systolic blood pressure <= 135 mmHg
  • Kidney stones which are symptomatic and/or > 1 cm
  • History of abdominal surgery within the past 6 months
  • Heterogeneities in the kidneys (cysts or tumors)
  • Residual pyelonephritis
  • History of myocardial infarction, unstable angina pectoris, or cerebrovascular accident within the last 6 months
  • Hemodynamically significant valvular heart disease
  • Implantable cardioverter defibrillator, pacemaker, neurostimulator or other device incompatible with MRI
  • Body weight > 150 kilograms
  • Target treatment depth > 14 cm from the skin line
  • Pregnant, nursing or intends to become pregnant during the trial period

Sites / Locations

  • St. Anne's University Hospital
  • Nemocnice Na Homolee Hospital
  • Mercy Angiography

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Renal Denervation

Arm Description

Renal Denervation using the Kona Surround Sound Externally Focused Therapeutic Ultrasound therapy.

Outcomes

Primary Outcome Measures

Safety
Safety will be assessed by incidence and evaluation of any serious adverse effects associated with the investigational procedure through 52-week evaluation. Included in this assessment will be the proportion of subjects with any of the following outcomes: 1) death, or 2) medical morbidity.

Secondary Outcome Measures

Clinical Utility
Clinical utility will be evaluated by comparing pre and post therapy systolic and diastolic blood pressure.

Full Information

First Posted
August 19, 2013
Last Updated
October 27, 2015
Sponsor
Kona Medical Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT01926951
Brief Title
Renal Denervation Using Externally Focused Therapeutic Ultrasound
Official Title
A Feasibility Study: An Evaluation of Renal Denervation Using Externally Focused Therapeutic Ultrasound With External Targeting and Tracking on Patients With Refractory Hypertension
Study Type
Interventional

2. Study Status

Record Verification Date
October 2015
Overall Recruitment Status
Completed
Study Start Date
September 2013 (undefined)
Primary Completion Date
June 2015 (Actual)
Study Completion Date
June 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Kona Medical Inc.

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study will evaluate the effects of renal denervation using externally focused therapeutic ultrasound with external targeting and tracking on patients with refractory hypertension.
Detailed Description
This study is a prospective, multi-center trial wherein each included subject will receive the experimental externally focused ultrasound renal denervation therapy. It will be conducted on a maximum of twenty patients who meet the eligibility criteria and have signed the informed consent form. Safety is the primary endpoint of this study. Safety will be assessed by incidence and evaluation of any serious adverse effects associated with the investigational procedure through the 52-week evaluation. Clinical utility is a secondary endpoint of this study. Clinical utility will be evaluated by comparing pre and post therapy systolic and diastolic blood pressure.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
hypertension

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
27 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Renal Denervation
Arm Type
Experimental
Arm Description
Renal Denervation using the Kona Surround Sound Externally Focused Therapeutic Ultrasound therapy.
Intervention Type
Device
Intervention Name(s)
Surround Sound Externally Focused Therapeutic Ultrasound
Intervention Description
Externally Focused Therapeutic Ultrasound using the Kona Surround Sound System
Primary Outcome Measure Information:
Title
Safety
Description
Safety will be assessed by incidence and evaluation of any serious adverse effects associated with the investigational procedure through 52-week evaluation. Included in this assessment will be the proportion of subjects with any of the following outcomes: 1) death, or 2) medical morbidity.
Time Frame
52-week post-treatment
Secondary Outcome Measure Information:
Title
Clinical Utility
Description
Clinical utility will be evaluated by comparing pre and post therapy systolic and diastolic blood pressure.
Time Frame
52-week post-treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: At least 18 years of age Average systolic blood pressure at least 160 mmHg Refractory, stable hypertension despite being treated with at least three hypertensive drugs Two functioning kidneys, defined as eGFR >= 45 ml/min At least one renal artery on each side which is greater than 4 mm. Exclusion Criteria: History of nephrectomy or hydronephrosis Renal stenosis > 50% Renal stent Ambulatory blood pressure monitoring 24 hour average systolic blood pressure <= 135 mmHg Kidney stones which are symptomatic and/or > 1 cm History of abdominal surgery within the past 6 months Heterogeneities in the kidneys (cysts or tumors) Residual pyelonephritis History of myocardial infarction, unstable angina pectoris, or cerebrovascular accident within the last 6 months Hemodynamically significant valvular heart disease Implantable cardioverter defibrillator, pacemaker, neurostimulator or other device incompatible with MRI Body weight > 150 kilograms Target treatment depth > 14 cm from the skin line Pregnant, nursing or intends to become pregnant during the trial period
Facility Information:
Facility Name
St. Anne's University Hospital
City
Brno
Country
Czech Republic
Facility Name
Nemocnice Na Homolee Hospital
City
Prague
Country
Czech Republic
Facility Name
Mercy Angiography
City
Aukland
Country
New Zealand

12. IPD Sharing Statement

Learn more about this trial

Renal Denervation Using Externally Focused Therapeutic Ultrasound

We'll reach out to this number within 24 hrs